Showing results (1221-1230 of 3,182) with videos related to

Sort By:
Pageof 319
Translational Oncology|June 25, 2014
Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patientsKyle C Cuneo, Mary A Davis, Mary U Feng, et al.
Translational Oncology|June 28, 2014
Characterization of the inflammatory microenvironment and identification of potential therapeutic targets in wilms tumorsParamahamsa Maturu, Willem W Overwijk, John Hicks, et al.
Translational Oncology|June 18, 2014
Activation of oncogenic pathways in idiopathic pulmonary fibrosisGiulia M Stella, Simona Inghilleri, Ymera Pignochino, et al.
Translational Oncology|May 22, 2023
Loss of BCAA catabolism enhances Rab1A-mTORC1 signaling activity and promotes tumor proliferation in NSCLCMeiting Xue, Jiawei Xiao, Wenna Jiang, et al.
Translational Oncology|July 12, 2020
Candidate biomarker assessment for pharmacological responseWilliam C Reinhold, Fathi Elloumi, Sudhir Varma, et al.
Translational Oncology|July 12, 2020
Quantifying DNA damage induced by ionizing radiation and hyperthermia using single DNA molecule imagingVandana Singh, Pegah Johansson, Dmitry Torchinsky, et al.
Translational Oncology|July 12, 2020
CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastomaJuliana Cano-Mejia, Anshi Shukla, Debbie K Ledezma, et al.
Translational Oncology|July 4, 2020
Prognostic Indicators for Gastrointestinal Stromal Tumors: A ReviewHaixin Zhang, Qi Liu
Translational Oncology|July 6, 2020
Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcomaJichuan Wang, Kenji Sato, Ed O'Donnell, et al.
Translational Oncology|July 5, 2020
The neural stem-cell marker CD24 is specifically upregulated in IDH-mutant gliomaPatricia D B Tiburcio, Mary C Locke, Srividya Bhaskara, et al.
Pageof 319